Model-Based Approach for Designing an Efficient Bioequivalence Study for Highly Variable Drugs

The statistical procedures as outlined by the European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) guidelines for bioequivalence testing of highly variable drugs (HVDs) are complex. Additionally, the sample size is affected by clinical study designs or practical real-...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Eunjung Song, Woojoo Lee, Bo-Hyung Kim
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	MDPI AG 2021-10-01
Ráidu:	Pharmaceuticals
Fáttát:	highly variable drugs reference-scaled average bioequivalence pharmacokinetic model
Liŋkkat:	https://www.mdpi.com/1424-8247/14/11/1101
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!